Saleha Anwar, PhD

Dr. Saleha Anwar is an Adjunct Faculty Member and Principal Investigator on a cancer biology research project at Ajman University, United Arab Emirates. Her research focuses on understanding the molecular mechanisms of cancer progression and identifying potential therapeutic strategies, with a particular interest in translational oncology. She has been consistently recognized for her scientific excellence and contributions, receiving several Young Researcher Awards at prestigious international conferences. Dr. Anwar also holds distinguished national research fellowships, including the CSIR-NET, ICMR-SRF, and the highly competitive DBT-Research Associateship (DBT-RA), reflecting her academic rigor and dedication to biomedical research. Her work bridges academic study and practical application, and she continues to mentor students and collaborate with scientists across disciplines to advance cancer biology. She has contributed to scientific literature with several publications.

1. Mechanistic insights into the inhibition of microtubule affinity-regulating kinase 4 by Syringic acid: Shahwan, M., Yadav, D.K., Khan, M.S., Choudhury, A., Shamsi, A., Hassan, M.I. and Anwar, S., 2025. A computational and experimental study. International Journal of Biological Macromolecules, 309, p.142812.

2.Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy. Anwar, S., Shamsi, A., Mohammad, T., Islam, A. and Hassan, M.I., 2021. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 1876(1), p.188568.

3.Rosmarinic acid exhibits anticancer effects via MARK4 inhibition. Anwar, S., Shamsi, A., Shahbaaz, M., Queen, A., Khan, P., Hasan, G.M., Islam, A., Alajmi, M.F., Hussain, A., Ahmad, F. and Hassan, M.I., 2020. Scientific Reports, 10(1), p.10300.